<h1>Pharma firm launches IPO Sept 1-3, 2025 for up to 10,000,000 equity shares at ?120-?126 per share</h1> A pharmaceutical company has filed for an initial public offering opening September 1, 2025 and closing September 3, 2025, seeking up to 1,00,00,000 equity shares (face value ?10) at a price band of ?120-?126 to raise up to ?12,600 lakhs, with proposed listings on national stock exchanges. Allocation: up to 50,00,000 shares to qualified institutional buyers, at least 15,00,000 to non-institutional investors and at least 35,00,000 to individual investors; anchor portion opens August 29, 2025. Net proceeds will fund civil construction, equipment and machinery for two new sterile-liquid manufacturing lines and general corporate purposes. Lead manager and registrar appointed.